Sigridur Elin Gudlaugsdottir
Human Resources Officer bij Alvotech hf
Oorsprong van het eerstegraads netwerk van Sigridur Elin Gudlaugsdottir
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Sigridur Elin Gudlaugsdottir via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Henley Business School Ltd. | College/University | Masters Business Admin | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal | |
| KUNWHA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
| University of Lakehead | College/University | Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin | |
| University of Florida | College/University | Doctorate Degree | |
| Chalmers University of Technology | College/University | Graduate Degree | |
| Georgetown University | College/University | Undergraduate Degree | |
| University of Warwick | College/University | Masters Business Admin | |
| University of Portsmouth | College/University | Undergraduate Degree | |
| Loughborough University | College/University | Doctorate Degree | |
| Radboud University Nijmegen | College/University | Graduate Degree | |
| Northeastern University (China) | College/University | Masters Business Admin | |
| University of Iceland | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
3i Nordic Plc
 3i Nordic Plc Investment ManagersFinance 3i Nordic Plc (3i Nordic) is the Swedish venture capital subsidiary of 3i Group Plc (LSE: III) in Great Britain. Formerly known as Atle AB, founded in 1993, the firm was acquired by 3i in 2001 and renamed 3i Nordic. Located in Stockholm, 3i Nordic utilizes specialized 3i Group resources to provide financial experience, sector knowledge, company management practice and access to 3i's network of international contacts to investee companies. 3i Nordic is part of the 3i Nordic investment team which includes investment professionals from the Helsinki and Copenhagen offices. | Investment Managers | Chief Executive Officer | |
Deloitte & Touche hf
 Deloitte & Touche hf Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte & Touche hf provides accounting and financial advice. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| BONESUPPORT HOLDING AB | Medical Specialties | Chief Executive Officer | |
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LOTUS PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Chairman | |
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CVC Advisers International Svenska Filial | Investment Managers | Private Equity Investor | |
Alvogen Pharma US, Inc.
 Alvogen Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Alvogen Pharma US, Inc. engages in the development, manufacturing and distributing generic, brand, over-the-counter brands and biosimilar products. The company was founded in March 2012 and is headquartered in Morristown, NJ. | Pharmaceuticals: Major | Chief Executive Officer President | |
Alvogen Korea Holdings Ltd.
 Alvogen Korea Holdings Ltd. Pharmaceuticals: MajorHealth Technology Alvogen Korea Holdings Ltd. is a holding company, which engages in the development and manufacture of pharmaceutical products. Its products include medicine for urogenital system, circulatory system, diabetes, digestive system, nephrology division, dermatological division, respiratory system, antibiotics, hormone drug, health supplements, and pain reliever. The company was founded in 1958 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Alvogen Asia Pacific Holdings Ltd.
 Alvogen Asia Pacific Holdings Ltd. Pharmaceuticals: MajorHealth Technology Alvogen Asia Pacific Holdings Ltd. develops and manufactures drugs. The company is headquartered in Hong Kong. | Pharmaceuticals: Major | Director/Board Member | |
| Lögmannafélag Íslands | Corporate Officer/Principal | ||
| Istanbul Kültür University | College/University | Undergraduate Degree | |
| Case Western Reserve University School of Law | College/University | Graduate Degree | |
BONE SUPPORT AB
 BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Chief Executive Officer | |
| BIODEXA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
Bone Support Incentive AB
 Bone Support Incentive AB Real Estate DevelopmentFinance Part of BONESUPPORT HOLDING AB, Bone Support Incentive AB provides real estate services. The company is based in Lund, Sweden. | Real Estate Development | Chairman | |
Alvogen Group, Inc.
 Alvogen Group, Inc. Pharmaceuticals: MajorHealth Technology Part of Alvogen, Inc., Alvogen Group, Inc. is a pharmaceutical company that offers a unique portfolio of high-quality and difficult-to-make pharmaceutical products. The company is based in Pine Brook, NJ. The company's targeted growth strategy is fueled by providing affordable generic medications that help reduce healthcare costs globally. | Pharmaceuticals: Major | Director/Board Member | |
| Kunwha Pharmaceutical Co., Ltd. | Director/Board Member Director/Board Member | ||
Alvogen Iceland ehf
 Alvogen Iceland ehf Pharmaceuticals: MajorHealth Technology Alvogen Iceland ehf develops, manufactures and distributes generic pharmaceutical products. It offers Eradizol, Kalmente, Eubiotic, Windi, Zinkspray, and Aftamed. The company was founded in 2010 and is headquartered in Reykjavik, Iceland. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Auregen Biotherapeutics SA
 Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland. | Packaged Software | Chief Executive Officer | |
Auregen Biotherapeutics, Inc.
 Auregen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auregen Biotherapeutics, Inc. provides biotechnology services. The CEO of the American company is Richard John Davies. | Miscellaneous Commercial Services | Chief Executive Officer | |
Alvogen Emerging Markets Holdings Ltd.
 Alvogen Emerging Markets Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of Celtic Holdings SCA, Alvogen Emerging Markets Holdings Ltd. is a Chinese pharmaceutical company that offers high-quality, affordable generic medications to reduce healthcare costs globally. The company is based in Wanchai, Hong Kong. The company's growth strategy is fueled by a unique portfolio of high-quality and difficult-to-make pharmaceutical products. Alvogen's sister company, Alvotech, specializes in the development and manufacturing of high-quality biosimilar medicines. The company was founded in 2009 by Vilhelm Róbert Wessman, who has been the CEO since 2009. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ALVOTECH | Biotechnology | Director/Board Member General Counsel Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Operating Officer Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Adalvo Ltd.
 Adalvo Ltd. Pharmaceuticals: MajorHealth Technology Adalvo Ltd. is a pharmaceutical company with headquarters in an undisclosed location and additional offices in over 15 countries. The private company is based in an undisclosed location and has subsidiaries in over 15 countries, including the United States and India. The Maltese company takes a unique and customized approach to help its partners achieve their business goals in the dynamic pharmaceutical sector. Adalvo is committed to accelerating the growth and development of its employees and local communities while striving for excellence in all its endeavors. The company's purpose-driven culture is focused on improving the lives of patients worldwide. Adalvo has a dynamic leadership team with significant experience and industry know-how. The CEO of the company is Anil Okay. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Schreiner Medipharm | President | ||
| Amgen Australia Pty Ltd. | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 16 |
| Zweden | 7 |
| Verenigd Koninkrijk | 6 |
| IJsland | 5 |
| Zuid-Korea | 4 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 16 |
| Commercial Services | 4 |
| Finance | 4 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 58 |
| Corporate Officer/Principal | 36 |
| Chief Executive Officer | 22 |
| Chairman | 16 |
| Undergraduate Degree | 11 |
Sterkste connecties
| Insiders | |
|---|---|
| Vilhelm Wessman | 23 |
| Linda McGoldrick | 21 |
| Tomas Ekman | 19 |
| Helga Zharov | 15 |
| Richard Davies | 15 |
| Árni Harðarson | 13 |
| Anil Okay | 12 |
| Lisa Graver | 10 |
| Ann Merchant | 8 |
| Joel Morales | 6 |
| Faysal Kalmoua | 6 |
| Joseph E. McClellan | 6 |
| Sean Gaskell | 5 |
| Ming Li | 4 |
- Beurs
- Insiders
- Sigridur Elin Gudlaugsdottir
- Bedrijfsconnecties
